Home LiteratureArticle Details
PMID: 9169770 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

High-level heterologous expression and secretion in rapidly growing nonpathogenic mycobacteria of four major Mycobacterium tuberculosis extracellular proteins considered to be leading vaccine candidates and drug targets.

Infection and immunity ·Vol. 65 ·No. 6 ·1997-06-00 ·Pages 2321-8

Harth G, Lee BY, Horwitz MA

Abstract

Mycobacterium tuberculosis, the primary etiologic agent of tuberculosis, is the world's leading cause of death from a single infectious agent, and new vaccines and drugs to combat it are urgently needed. The major extracellular proteins of M. tuberculosis, which are released into its phagosome in macrophages, its host cells in humans, are leading candidates for a vaccine and prime targets for new drugs. However, the development of these biologicals has been hampered by the unavailability of large quantities of recombinant extracellular proteins identical to their native counterparts. In this report, we describe the heterologous expression and secretion of four major M. tuberculosis extracellular proteins (the 30-, 32, 16-, and 23.5-kDa proteins--the first, second, third, and eighth most abundant, respectively) in rapidly growing, nonpathogenic mycobacterial species. Multiple attempts to obtain secretion of the proteins by using Escherichia coli- and Bacillus subtilis-based expression systems were unsuccessful, suggesting that high-level expression and secretion of these Mycobacterium-specific proteins require a mycobacterial host. All four recombinant proteins were stably expressed from the cloned genes' own promoters at yields that were 5- to 10-fold higher than those observed for the native proteins. The four proteins were purified to apparent homogeneity from culture filtrates by ammonium sulfate precipitation and ion-exchange and molecular sieve chromatography. The recombinant proteins were indistinguishable from their native counterparts by multiple criteria. First, N-terminal amino acid sequence determination demonstrated that processing of the leader peptides was highly accurate. Second, sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis revealed identical migration patterns. Third, mass spectrometry analysis confirmed that differences in mass were < or = 5 Da. A homolog of the M. tuberculosis 30-kDa protein was identified in M. smegmatis by means of DNA analyses and immunoscreening. This is the first time that secretion of recombinant M. tuberculosis extracellular proteins in their native form has been achieved. This study opens the door to mass production of correctly processed and secreted extracellular proteins of M. tuberculosis in a heterologous host and allows ready evaluation of their biologic and immunologic function.

MeSH Terms
Amino Acid Sequence Bacterial Proteins/biosynthesis,genetics,immunology Bacterial Vaccines/biosynthesis Chromosome Mapping DNA, Bacterial/chemistry Gene Amplification Immunoblotting Molecular Sequence Data Molecular Weight Mycobacterium tuberculosis/chemistry,immunology Promoter Regions, Genetic Recombinant Proteins/biosynthesis,immunology,isolation & purification
Chemicals
Bacterial Proteins Bacterial Vaccines DNA, Bacterial Recombinant Proteins
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Harth G
Department of Medicine, School of Medicine, University of California, Los Angeles 90095, USA.
Lee B Y
Horwitz M A
References (23)
23 references, click to expand
  1. The 3'-terminal sequence of Escherichia coli 16S ribosomal RNA: complementarity to nonsense triplets and ribosome binding sites.
    Proc Natl Acad Sci U S A. 1974 Apr;71(4):1342-6 PMID: 4598299
  2. Novel insights into the genetics, biochemistry, and immunocytochemistry of the 30-kilodalton major extracellular protein of Mycobacterium tuberculosis.
    Infect Immun. 1996 Aug;64(8):3038-47 PMID: 8757831
  3. DNA sequencing with chain-terminating inhibitors.
    Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463-7 PMID: 271968
  4. Cloning restriction fragments that promote expression of a gene in Bacillus subtilis.
    J Bacteriol. 1981 Jun;146(3):1162-5 PMID: 6787015
  5. Production in B. subtilis of hepatitis B core antigen and a major antigen of foot and mouth disease virus.
    Nature. 1981 Oct 8;293(5832):481-3 PMID: 6273732
  6. Genomic sequencing.
    Proc Natl Acad Sci U S A. 1984 Apr;81(7):1991-5 PMID: 6326095
  7. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors.
    Gene. 1985;33(1):103-19 PMID: 2985470
  8. Mechanism and control of transcription initiation in prokaryotes.
    Annu Rev Biochem. 1985;54:171-204 PMID: 3896120
  9. "ATG vectors' for regulated high-level expression of cloned genes in Escherichia coli.
    Gene. 1985;40(2-3):183-90 PMID: 3007288
  10. A new method for predicting signal sequence cleavage sites.
    Nucleic Acids Res. 1986 Jun 11;14(11):4683-90 PMID: 3714490
  11. Purification and characterization of a novel mycolic acid exchange enzyme from Mycobacterium smegmatis.
    J Biol Chem. 1987 Oct 5;262(28):13417-23 PMID: 3654621
  12. Biochemical and antigenic characterization of the Mycobacterium tuberculosis 71kD antigen, a member of the 70kD heat-shock protein family.
    Mol Microbiol. 1989 Feb;3(2):125-30 PMID: 2503672
  13. Genetic analysis of superoxide dismutase, the 23 kilodalton antigen of Mycobacterium tuberculosis.
    Mol Microbiol. 1991 Feb;5(2):381-91 PMID: 1904126
  14. Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis.
    Infect Immun. 1992 Nov;60(11):4781-92 PMID: 1398989
  15. DNA sequence, structure and gene expression of mycobacteriophage L5: a phage system for mycobacterial genetics.
    Mol Microbiol. 1993 Feb;7(3):395-405 PMID: 8459766
  16. Control of transcription termination by RNA-binding proteins.
    Annu Rev Biochem. 1993;62:893-930 PMID: 8352604
  17. Transformation of mycobacterial species using hygromycin resistance as selectable marker.
    Microbiology. 1994 Jan;140 ( Pt 1):133-8 PMID: 8162182
  18. Cloning and B-cell-epitope mapping of MPT64 from Mycobacterium tuberculosis H37Rv.
    Infect Immun. 1994 May;62(5):2058-64 PMID: 7513311
  19. Glutamine synthetase of Mycobacterium tuberculosis: extracellular release and characterization of its enzymatic activity.
    Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9342-6 PMID: 7937767
  20. Analysis of the Mycobacterium tuberculosis 85A antigen promoter region.
    J Bacteriol. 1995 Feb;177(3):642-53 PMID: 7836298
  21. Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis.
    Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1530-4 PMID: 7878014
  22. Identification of macrophage and stress-induced proteins of Mycobacterium tuberculosis.
    J Clin Invest. 1995 Jul;96(1):245-9 PMID: 7615794
  23. An integrated map of the genome of the tubercle bacillus, Mycobacterium tuberculosis H37Rv, and comparison with Mycobacterium leprae.
    Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):3132-7 PMID: 8610181
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1997-06-00
Pages
2321-8
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC175322
Subset
IM
Grants
NIAID NIH HHS · AI-07126 · United States
NIAID NIH HHS · AI-31338 · United States
Databases
GENBANK
U82234, U82235
Corrections
ErratumIn
-
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com